NCT06546332 - Post Market Clinical Follow-Up KeriFuse® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2027

Conditions

Arthritis

Interventions

DEVICE

KeriFuse®

The intramedullary arthrodesis Implant (KeriFuse®) is indicated for consolidation or bone fusion (arthrodesis) of degraded or arthritic distal interphalangeal (DIP) of hand digits or interphalangeal (IP) joint of the hand thumb.

Trial Locations (6)

13090

Centre de la main du Pays d'Aix, Aix-en-Provence

24000

Clinique du Parc, Périgueux

38300

Centre Ostéo Articulaire Fleming, Bourgoin

63110

Clinique de la Chataigneraie, Beaumont

66000

Clinique Mutualiste Catalane, Perpignan

06000

Clinique Saint François, Nice